Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of GRT7014 vs Norco in Healthy Subjects
NCT03137017Phase 1Withdrawn
- Sponsor
- Grünenthal GmbH
- Start
- Sep 2017
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of GRT7014 in pain (4 arms), sponsored by Grünenthal GmbH. Primary endpoints: Maximum Plasma Concentration, Area under the plasma concentration curve from timepoint 0 to t and 1 more. Planned start Sep 2017; status: withdrawn.
02
Drugs
GRT7014
03
Conditions
pain
Beyond the preview
Go deeper on NCT03137017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03137017.